These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31487346)

  • 1. Solar urticaria treated with omalizumab.
    Schaffenburg WC; Guerrero KT; Marks SN
    Cutis; 2019 Jul; 104(1):E4-E5. PubMed ID: 31487346
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of omalizumab in severe solar urticaria.
    de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest.
    Combalia A; Fernández-Sartorio C; Aguilera P
    Actas Dermosifiliogr; 2017; 108(6):593-594. PubMed ID: 28168968
    [No Abstract]   [Full Text] [Related]  

  • 4. Incapacitating solar urticaria: successful treatment with omalizumab.
    Kieselova K; Santiago F; Henrique M
    An Bras Dermatol; 2019 Jul; 94(3):331-333. PubMed ID: 31365663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solar urticaria caused by visible light in a 33-year-old male refractory to treatment with omalizumab.
    Wright E; Kurland E; Lim HW
    Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):316-317. PubMed ID: 32141097
    [No Abstract]   [Full Text] [Related]  

  • 6. Solar urticaria induced by visible light: successful treatment with omalizumab.
    Terrani I; Bircher AJ; Scherer Hofmeier K
    Clin Exp Dermatol; 2016 Dec; 41(8):890-892. PubMed ID: 27766671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature.
    Snast I; Kremer N; Lapidoth M; Enk CD; Tal Y; Rosman Y; Confino-Cohen R; Hodak E; Levi A
    J Allergy Clin Immunol Pract; 2018; 6(4):1198-1204.e3. PubMed ID: 29572192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term treatment with omalizumab in adolescent with refractory solar urticaria.
    Iannelli M; Passanisi S; Crisafulli G; Arasi S; Caminiti L; Zirilli G; Pajno GB
    Ital J Pediatr; 2021 Sep; 47(1):195. PubMed ID: 34583772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial improvement of solar urticaria after omalizumab.
    Waibel KH; Reese DA; Hamilton RG; Devillez RL
    J Allergy Clin Immunol; 2010 Feb; 125(2):490-1. PubMed ID: 20159260
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Omalizumab changed my life': a patient perspective on solar urticaria.
    Parkin D; Ling TC; Ayer J; Rhodes LE; Rutter KJ
    Clin Exp Dermatol; 2024 Jul; 49(8):935-936. PubMed ID: 38491908
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
    Geller M
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
    [No Abstract]   [Full Text] [Related]  

  • 12. Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial.
    Metz M; Schütz A; Weller K; Gorczyza M; Zimmer S; Staubach P; Merk HF; Maurer M
    J Allergy Clin Immunol; 2017 Sep; 140(3):864-867.e5. PubMed ID: 28389393
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness in the treatment of solar urticaria with omalizumab: Report of 7 cases.
    Sahuquillo-Torralba A; Rodríguez-Serna M; Botella Estrada R
    Med Clin (Barc); 2018 Dec; 151(11):460-461. PubMed ID: 29526307
    [No Abstract]   [Full Text] [Related]  

  • 14. Cover Image: Local cutaneous refractoriness to sun exposure following omalizumab injections in solar urticaria.
    McSweeney SM; Bintcliffe K; Fassihi H; Sarkany R; Rutkowski C
    Br J Dermatol; 2023 Apr; 188(5):e34. PubMed ID: 36703220
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of refractory cholinergic urticaria with omalizumab.
    Koumaki D; Seaton ED
    Int J Dermatol; 2018 Jan; 57(1):114. PubMed ID: 29057464
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria.
    Arasi S; Crisafulli G; Caminiti L; Guarneri F; Aversa T; Porcaro F; Pajno GB
    Pediatr Allergy Immunol; 2015 Sep; 26(6):583-5. PubMed ID: 26033828
    [No Abstract]   [Full Text] [Related]  

  • 17. Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study.
    Aubin F; Avenel-Audran M; Jeanmougin M; Adamski H; Peyron JL; Marguery MC; Léonard F; Puyraveau M; Viguier M;
    J Am Acad Dermatol; 2016 Mar; 74(3):574-5. PubMed ID: 26892659
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.
    Levi A; Tal Y; Dranitzki Z; Shalit M; Enk CD
    Pediatr Allergy Immunol; 2015 Sep; 26(6):588-90. PubMed ID: 26172942
    [No Abstract]   [Full Text] [Related]  

  • 19. Omalizumab as Third-Line Therapy for Urticaria During Pregnancy.
    Ensina LF; Cusato-Ensina AP; Camelo-Nunes IC; Solé D
    J Investig Allergol Clin Immunol; 2017; 27(5):326-327. PubMed ID: 29057743
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical response and long-term follow-up of 20 patients with refractory solar urticaria under treatment with omalizumab.
    Morgado-Carrasco D; Giácaman-Von der Weth M; Fustá-Novell X; Podlipnik S; Pérez-Ferriols A; Aguilera P
    J Am Acad Dermatol; 2023 May; 88(5):1110-1111. PubMed ID: 31150709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.